Popular lifehacks

Will Arimistane shut you down?

Will Arimistane shut you down?

Arimistane is a “suicide” aromatase inhibitor because once it binds to aromatase, it binds to it for life and shuts it down for good.

What is Arimistane used for?

Arimistane is used for weight loss, to improve athletic performance, to reduce sexual problems, and for other uses, but there is no good scientific evidence to support its use.

Are there any alternatives to aromatase inhibitors?

Tamoxifen is the first choice for premenopausal women while aromatase inhibitors are used primarily for postmenopausal women; however, in cases where postmenopausal women cannot tolerate aromatase inhibitors, Tamoxifen may provide an alternative option.

How good is Arimistane?

READ ALSO:   Can a child be dyslexic but good at maths?

It increases testosterone levels in the body. It is banned by the World Anti-Doping Agency (WADA). Arimistane is used for weight loss, to improve athletic performance, to reduce sexual problems, and for other uses, but there is no good scientific evidence to support its use. Arimistane might also be unsafe.

What is the half life of Arimistane?

The half-life of Arimistane (Androsta-3 5-diene-7 17-dione) is said to be between 2 to 4 hours. Due to the short half-life, it is recommended to spread your dosage throughout the day. By spreading the dosage, you will be able to maintain this compound’s stable levels in your system.

What are the long term side effects of aromatase inhibitors?

Aromatase inhibitors tend to cause fewer serious side effects than tamoxifen, such as blood clots, stroke, and endometrial cancer. But aromatase inhibitors can cause more heart problems, more bone loss (osteoporosis), and more broken bones than tamoxifen, at least for the first few years of treatment.

READ ALSO:   Is sugar in the Raw healthier than white sugar?

Why aromatase inhibitor is bad for you?

Do all aromatase inhibitors cause joint pain?

While aromatase inhibitors are very effective, they have potential side effects. Studies have found that anywhere from 25\% to 50\% of women who take the drugs experience joint pain or muscle pain.